Researchers in Japan find that tapering or reducing benzodiazepines has a positive effect on quality of life, verbal and working memory, and psychiatric symptoms in people with a schizophrenia diagnosis, with no adverse effects. The study found that a daily dose reduction strategy of 25-50% per 2-4 weeks was safe. The study appears in the upcoming issue of Progress in Neuro-Psychopharmacology and Biological Psychiatry.
Read more                          Discuss →